Shulei Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shulei Zhang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Dangheng Wei
Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China
2 shared publications - Gaosheng Xu
Department of Breast Surgery, Yueyang Maternal and Child Health-Care Hospital, Yueyang 414000, Hunan Province, China
1 shared publication Jiaxiong Wu
Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, Province Innovative Training Base for Medical Postgraduates, Hengyang Medical College, University of South China, Hengyang, Hunan, China
1 shared publication- Jinna Chen
Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, Hunan Province Innovative Training Base for Medical Postgraduate, University of South China and Yueyang Woman & Children's Medical Center, Hengyang Medical College, University of South China, Hengyang, Hunan, China
1 shared publication Lu Li
Key Laboratory for Arteriosclerology of Hunan Province, Institute of Cardiovascular Disease, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, University of South China, Hengyang, China
1 shared publication- Peng Wu
Hengyang Maternal and Child Health Hospital, Hengyang 421001, Hunan Province, China
1 shared publication
Latest Publications
- 1 March 2022
- Published by SAGE Publications in DNA and Cell Biology
- Vol. 41 (3) , 285-291
Succinate: A Novel Mediator to Promote Atherosclerotic Lesion Progression
Succinate is an important intermediate product of mitochondrial energy metabolism. Recent studies revealed that beyond its known traditional metabolic functions, succinate plays important roles in signal transduction, immunity, inflammation, and posttranslational modification. Recent studies showed that patients and mouse models with cardiovascular disease have high levels of serum succinate and succinate accumulation. Atherosclerosis (As) is the pathological basis of cardiovascular and peripheral vascular diseases, such as coronary heart disease, cerebral infarction, and peripheral vascular disease, and is a major factor affecting human health. This article reviews the progression of succinate in As diseases and its underlying mechanisms.
- 1 March 2022
- Published by SAGE Publications in DNA and Cell Biology
- Vol. 41 (3) , 285-291
Succinate: A Novel Mediator to Promote Atherosclerotic Lesion Progression
Succinate is an important intermediate product of mitochondrial energy metabolism. Recent studies revealed that beyond its known traditional metabolic functions, succinate plays important roles in signal transduction, immunity, inflammation, and posttranslational modification. Recent studies showed that patients and mouse models with cardiovascular disease have high levels of serum succinate and succinate accumulation. Atherosclerosis (As) is the pathological basis of cardiovascular and peripheral vascular diseases, such as coronary heart disease, cerebral infarction, and peripheral vascular disease, and is a major factor affecting human health. This article reviews the progression of succinate in As diseases and its underlying mechanisms.
- 8 January 2020
- Published by SAGE Publications in DNA and Cell Biology
- Vol. 39 (1) , 8-15
Essential Role of Nonessential Amino Acid Glutamine in Atherosclerotic Cardiovascular Disease
Atherosclerosis is a major disease that seriously harms human health and is known as the “number one killer” in developed countries and the leading cause of death worldwide. Glutamine is the most abundant nonessential amino acid in the human blood that has multifaceted effects on the body. Recent studies showed that glutamine is negatively corrected with the progression of atherosclerotic lesions. In this review, we focused on the relationship of glutamine with macrophage polarization, nitrification stress, oxidative stress injury, myocardial ischemia–reperfusion injury, and therapeutic angiogenesis to review its roles in atherosclerotic cardiovascular disease.
- 8 January 2020
- Published by SAGE Publications in DNA and Cell Biology
- Vol. 39 (1) , 8-15
Essential Role of Nonessential Amino Acid Glutamine in Atherosclerotic Cardiovascular Disease
Atherosclerosis is a major disease that seriously harms human health and is known as the “number one killer” in developed countries and the leading cause of death worldwide. Glutamine is the most abundant nonessential amino acid in the human blood that has multifaceted effects on the body. Recent studies showed that glutamine is negatively corrected with the progression of atherosclerotic lesions. In this review, we focused on the relationship of glutamine with macrophage polarization, nitrification stress, oxidative stress injury, myocardial ischemia–reperfusion injury, and therapeutic angiogenesis to review its roles in atherosclerotic cardiovascular disease.